Sweat testing remains the "gold standard" for the diagnosis of cystic fibrosis (CF) and is a critical component of newborn screening programs. We retrospectively reviewed sweat test results reported to a neonatal screening program for CF with respect to completeness of reported results and the value
Cochrane review: Newborn screening for cystic fibrosis
✍ Scribed by Kevin W Southern; Marieke M. E. Mérelle; Jeannette E Dankert-Roelse; Ad Nagelkerke
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 344 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1557-6272
- DOI
- 10.1002/ebch.463
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
O bstetricians should offer all women cystic fibrosis (CF) screening, regardless of their ethnic background, the American Congress of Obstetricians and Gynecologists (ACOG) advises. An April ACOG Committee on Genetics opinion, published in the April issue of Obstetrics & Gynecology, suggests that o
## Abstract Cystic fibrosis (CF) is the most common life‐shortening genetically transmitted disease in Denmark with a birth prevalence of 1 in 4700, resulting in 12–15 new cases of cystic fibroses annually. The aim of this study is to disclose the societal resource implications of introducing a po